Onderneming Relmada Therapeutics, Inc. OTC Markets
Aandelen
RLMD
US75955J4022
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,67 USD | 0,00% |
|
+8,91% | +139,13% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paolo Manfredi
FOU | Founder | 62 | 31-05-12 |
Sergio Traversa
CEO | Chief Executive Officer | 63 | - |
Maged Shenouda
DFI | Director of Finance/CFO | 59 | 12-11-15 |
Charles Ence
CMP | Compliance Officer | 64 | 29-07-19 |
John Hixon
PRN | Corporate Officer/Principal | - | 21-07-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 78 | 14-07-15 | |
Sergio Traversa
CEO | Chief Executive Officer | 63 | - |
Maged Shenouda
DFI | Director of Finance/CFO | 59 | 12-11-15 |
Fabiana Fedeli
BRD | Director/Board Member | 53 | 12-01-23 |
Director/Board Member | 61 | 19-12-19 | |
Paul Kelly
BRD | Director/Board Member | 65 | 12-11-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 30 174 202 | 27 748 959 ( 91,96 %) | 0 | 91,96 % |
Bedrijfsgegevens
Relmada Therapeutics, Inc.
2222 Ponce de Leon Boulevard 3rd floor
33134, Coral Gables
+786-629-1376
http://www.relmada.com![Adres Relmada Therapeutics, Inc.(RLMD)](https://cdn.zonebourse.com/static/address/23400702.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,42% | 126 mld. | |
+22,98% | 118 mld. | |
+23,26% | 27,87 mld. | |
-19,24% | 20,95 mld. | |
-15,13% | 16,92 mld. | |
-14,35% | 16,18 mld. | |
+9,35% | 14,84 mld. | |
-46,10% | 14,79 mld. | |
+50,64% | 14,08 mld. |
- Beurs
- Aandelen
- Koers RLMD
- Koers RLMD
- Onderneming Relmada Therapeutics, Inc.